10-K: Axon Reports Strong Revenue Growth Amid Profit Decline

Sentiment:

Annual Report


Axon Enterprise, Inc. reported a 33.5% increase in net sales to $2.8 billion for 2025, but net income significantly decreased to $124.7 million from $377.0 million in the prior year, alongside a material weakness in internal controls.

Capital raiseIssued $1.0 billion aggregate principal amount of Senior Notes due 2030 in March 2025.Issued $750.0 million aggregate principal amount of Senior Notes due 2033 in March 2025.Generated approximately $494.7 million in aggregate gross proceeds from sales under an at-the-market (ATM) equity offering program during 2025, with net proceeds of $489.4 million.
Worse than expectedNet income decreased significantly by 67% from $377.0 million in 2024 to $124.7 million in 2025.The company reported a loss from operations of $62.1 million in 2025, a reversal from an income of $58.5 million in 2024.Diluted EPS dropped from $4.80 in 2024 to $1.51 in 2025.Operating expenses increased substantially by $537.4 million, outpacing revenue growth and leading to the operating loss.A material weakness in internal control over financial reporting related to revenue recognition was identified, indicating a significant control deficiency.

Summary

  • Net sales for the year ended December 31, 2025, increased by 33.5% to $2.779 billion, up from $2.082 billion in 2024.
  • The Software and Services segment saw a 39.6% increase in net sales to $1.202 billion, driven by user growth and premium feature adoption, with annual recurring revenue (ARR) reaching $1.3 billion.
  • The Connected Devices segment's net sales grew by 29.1% to $1.576 billion, with TASER sales up 21.8%, Personal Sensors up 25.3%, and Platform Solutions surging by 72.5%.
  • The company reported a loss from operations of $62.1 million in 2025, a significant decline from an income of $58.5 million in 2024.
  • Net income decreased substantially to $124.7 million in 2025 from $377.0 million in 2024, resulting in diluted EPS of $1.51 compared to $4.80 in the prior year.
  • Operating expenses increased by $537.4 million, primarily due to higher headcount and a significant increase in stock-based compensation expense.
  • A material weakness in internal control over financial reporting related to revenue recognition for customer contracts was identified as of December 31, 2025.
  • Cash and cash equivalents increased by $746.3 million to $1.201 billion, and available-for-sale investments rose by $172.2 million to $505.4 million.
  • The company issued $1.75 billion in Senior Notes (2030 and 2033 maturities) and raised $489.6 million through an at-the-market (ATM) equity offering program.
  • Axon completed the acquisition of the remaining 99.2% interest in Prepared for approximately $624.1 million in cash, and subsequently acquired Carbyne Ltd. for $625.0 million in February 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed but predominantly negative report. While revenue growth is strong and strategic acquisitions are expanding market reach, the significant decline in profitability, the shift to an operating loss, and the identified material weakness in internal controls raise substantial concerns about operational efficiency and financial management.

Positives

  • Strong net sales growth of 33.5% year-over-year, reaching $2.779 billion.
  • Software and Services segment revenue increased by 39.6%, with Annual Recurring Revenue (ARR) hitting $1.3 billion, indicating robust subscription model performance.
  • Connected Devices segment revenue grew by 29.1%, with significant increases across TASER (21.8%), Personal Sensors (25.3%), and Platform Solutions (72.5%).
  • Cash and cash equivalents increased substantially by $746.3 million to $1.201 billion, enhancing liquidity.
  • Successful capital raise through $1.75 billion in Senior Notes and $489.6 million from an ATM equity offering.
  • Strategic acquisitions of Prepared and Carbyne (subsequent event) are expected to enhance public safety communications and emergency response solutions, and expand the end-to-end public safety ecosystem.
  • Adjusted gross margin for the Software and Services segment increased to 77.5% from 76.8%, driven by a higher software mix.
  • Employee growth of 24% in 2025, primarily in sales and R&D, and a low regrettable attrition rate of less than 1.0%, indicating strong talent attraction and retention.

Negatives

  • Net income significantly decreased to $124.7 million in 2025 from $377.0 million in 2024, representing a 67% drop.
  • The company reported a loss from operations of $62.1 million in 2025, a reversal from an income of $58.5 million in 2024.
  • Diluted net income per share decreased to $1.51 in 2025 from $4.80 in 2024.
  • Operating expenses increased by $537.4 million, driven by increased headcount and a substantial rise in stock-based compensation expense ($634.2 million in 2025 vs. $382.6 million in 2024).
  • Adjusted gross margin for the Connected Devices segment decreased to 51.2% from 53.6%, primarily due to a higher mix of Platform Solutions revenue and global tariffs.
  • Net interest position shifted from income of $36.6 million in 2024 to a loss of $18.8 million in 2025, largely due to the issuance of Senior Notes.
  • A net realized and unrealized loss of $46.4 million was recorded on marketable securities in 2025, compared to a gain of $120.3 million in 2024.
  • Operating cash flow decreased by $196.9 million to $211.3 million in 2025.
  • The company incurred $38.9 million in inducement expense associated with the early repurchase of a portion of its 2027 Notes.

Risks

  • Substantial dependence on continued acceptance of products and services by law enforcement agencies worldwide, with any reduction in demand materially adversely affecting the business.
  • Significant reliance on sales of Conducted Energy Devices (CEDs), where failure to maintain widespread market acceptance could diminish growth prospects.
  • Inability to successfully design, introduce, sell, and deploy new products or product features in a timely and cost-effective manner.
  • Exposure to rapid technological change and new competing products, particularly in AI and machine learning technologies.
  • Negative publicity potentially damaging the Axon brand, impacting sales, and causing revenues or operating results to decline.
  • Acquisitions or investments disrupting business, diluting shareholder value, or adversely affecting operating results due to integration challenges, unforeseen liabilities, or failure to realize anticipated benefits.
  • Challenges in managing rapid growth and planning for future expansion, straining management, operational, and financial resources.
  • Unavailability of materials or higher costs from U.S. domestic and international suppliers, including single-source components, tariffs, and trade restrictions.
  • Material adverse developments in domestic and global economic conditions (e.g., conflicts, interest rates, inflation, recession fears) affecting revenue and operations.
  • Delays in product development schedules impacting revenues and cash flows.
  • Significant resource expenditure during lengthy sales cycles without guaranteed revenue return.
  • Security breaches of company or third-party systems leading to unauthorized data access, undermining confidence, and causing legal/financial exposure.
  • Catastrophic events (e.g., natural disasters, cyber attacks, public health crises) disrupting business operations and financial condition.
  • Uncertainty in the development, deployment, and use of AI in products and services, including risks of failures, inaccuracies, bias, and evolving legal/regulatory landscape.
  • Defects or disruptions in services impacting demand, leading to substantial liability, and damaging reputation.
  • Defects in products potentially reducing demand, resulting in recalls, loss of sales, and reputational harm.
  • International operations exposing the company to additional risks such as foreign ownership restrictions, export controls, longer payment cycles, and legal uncertainties.
  • Dependence on the ability to attract and retain key management, sales, and technical personnel, including challenges with skilled professionals in data science and AI.
  • Failure to comply with federal, state, or local regulations applicable to the TASER 10 CED, which is classified as a firearm.
  • Failure to maintain effective internal control over financial reporting, which may adversely affect timely and accurate financial reporting.
  • Revision and restatement of previously issued consolidated financial statements potentially affecting investor confidence and leading to regulatory actions or litigation.
  • Increasing percentage of revenue from subscription billing arrangements resulting in delayed cash collections and increased customer credit risk.
  • Fluctuations in gross margin due to product mix, cost structure, and acquisitions.
  • SaaS revenue recognition over multi-year contract terms delaying the reflection of new business in operating results.
  • Government end-user customers being subject to budgetary and political constraints, which may delay or prevent sales or lead to contract non-renewal.
  • Uncertainty in securing future contract awards through the open bidding process.
  • Concentration of cash balances at three depository institutions, with some amounts uninsured, posing liquidity risks.
  • Stock transactions potentially having an unpredictable impact on operating results and resulting in dilution to existing shareholders.
  • Financial performance being subject to risks associated with changes in the value of the U.S. dollar versus local currencies.
  • Unanticipated changes in the effective tax rate and additional tax liabilities.
  • Quarter-to-quarter fluctuations in revenue and operating results impacting stock price.
  • Declines in fair value or impairment of investments, including strategic investments.
  • Personal injury, wrongful death, product liability, and other liability claims harming reputation and adversely affecting business.
  • Other litigation, government inquiries, and regulatory actions resulting in significant costs and judgments.
  • Intellectual property infringement and other claims incurring substantial litigation costs and inhibiting technology use.
  • Inability to protect intellectual property, decreasing brand value and competitive advantage.
  • Inability to enforce patent rights internationally, limiting ability to prevent competitors from using product features.
  • Use of open-source software exposing the company to additional risks and potentially harming intellectual property rights.
  • New and existing laws and/or interpretations (e.g., privacy, data protection, AI, content, competition, consumer protection) materially and adversely affecting the business.
  • Uncertainties with complex U.S. federal, state, local, and foreign procurement laws and regulations causing increased costs.
  • Evolving corporate governance and public disclosure regulations and expectations (e.g., ESG matters) exposing the company to numerous risks.
  • Exclusive forum provisions in amended and restated bylaws potentially increasing costs or limiting shareholder claims.
  • Fulfilling debt obligations requiring significant cash resources that may exceed available cash flow.
  • The 2027 Note Hedge and Warrant transactions potentially impacting the value of common stock.
  • Exposure to counterparty risk with respect to the 2027 Note Hedge transactions.
  • Indebtedness containing restrictive covenants that could limit operational flexibility and adversely affect common stock value.

Future Outlook

Axon expects to continue being an opportunistic issuer of debt securities to fund growth or refinance future debt maturities. The company anticipates sufficient funding to meet cash requirements for at least the next 12 months, including capital expenditures, working capital, potential acquisitions, and tax payments. Approximately 20-25% of the $9.9 billion in remaining performance obligations are expected to be recognized over the next 12 months, with the remainder substantially recognized over the following ten years.

Management Comments

  • Our integrated technology platform of hardware and software solutions advances our mission to (i) make the bullet obsolete, (ii) reduce social conflict, and (iii) enable a fair and effective justice system.
  • Our financial strategy is to build highly recurring, highly profitable businesses and to drive growth through purposeful product innovation.
  • We believe our network of camera sensors and digital evidence management platform give us a strategic advantage in these product categories (RMS and Axon Fusus).
  • We are committed to maintaining strong internal control over financial reporting.

Industry Context

StockSavvy.ai notes that Axon's strong revenue growth, particularly in its Software and Services segment and Platform Solutions, reflects a broader industry trend towards digital transformation and integrated technology solutions in public safety. The increasing adoption of AI-powered tools and drone technology aligns with the growing demand for advanced situational awareness and efficiency in law enforcement. However, the significant increase in operating expenses and the shift to an operating loss suggest that Axon is heavily investing in R&D and acquisitions to maintain its competitive edge in a rapidly evolving and highly fragmented market, where numerous competitors are also vying for market share in areas like digital evidence management, real-time operations, and counter-drone technology. The material weakness in internal controls could raise concerns about the scalability of financial processes amidst rapid expansion.

Comparison to Industry Standards

  • Axon's annual recurring revenue (ARR) of $1.3 billion as of December 31, 2025, demonstrates a strong recurring revenue model, which is a positive indicator compared to traditional hardware-focused companies in the public safety sector.
  • The 39.6% growth in the Software and Services segment outpaces many legacy public safety software providers, indicating successful penetration and adoption of its cloud-based SaaS solutions like Axon Evidence and Axon Records.
  • The 72.5% increase in Platform Solutions revenue, driven by counter-drone equipment and virtual reality training, highlights Axon's leadership in emerging public safety technologies, positioning it ahead of more specialized competitors like Dedrone (now acquired) and VirTra in these niche but growing markets.
  • The adjusted gross margin for Software and Services at 77.5% is competitive with leading SaaS companies, reflecting the high-margin nature of cloud-based offerings.
  • The decline in overall adjusted gross margin to 62.6% from 63.2% is a slight concern, particularly the drop in Connected Devices adjusted gross margin to 51.2% from 53.6%, which could be attributed to aggressive pricing or higher costs in hardware segments compared to industry peers like Motorola Solutions, which has a diversified portfolio and can leverage economies of scale.
  • The shift from operating income to an operating loss, despite strong revenue growth, suggests a higher investment rate in R&D and acquisitions compared to more mature, stable companies in the sector, indicating a growth-at-all-costs strategy that may be more aggressive than industry averages.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Information Security Officer (CISO)NACurrent CISO (name not specified)February 2024New appointment, bringing over 20 years of experience in information technology and information security.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Segment RealignmentRealigned business into two reportable segments: Connected Devices and Software and Services, effective January 1, 2025, to provide increased transparency and distinction.January 1, 2025Aims to better reflect continued growth and expansion of technology solutions, impacting how performance is assessed by the chief operating decision maker.
Credit Agreement AmendmentIncreased revolving credit facility by $100.0 million to $300.0 million, increased letter of credit availability to $50.0 million, and extended maturity date from December 15, 2027, to March 11, 2030.March 2025Enhances financial flexibility and liquidity, allowing for greater working capital and investment opportunities, while also permitting the issuance of new Senior Notes.
Bylaws Amendment (Exclusive Forum Provisions)Amended and restated bylaws include exclusive forum provisions designating the Chancery Court of Delaware for certain corporate actions and federal district courts for Securities Act claims.December 21, 2023 (reference to prior 8-K)Could increase costs to bring a claim, discourage claims, or limit shareholders' ability to bring claims in forums they view as more favorable, potentially reducing litigation risk for the company in certain jurisdictions.

Legal Proceedings

  • Three ongoing product liability lawsuits alleging wrongful death or personal injury related to TASER CED use by law enforcement, seeking compensatory and punitive damages.
  • A purported antitrust class action filed by three municipalities in the District of New Jersey (Case No. 3:23-cv-7182), based on allegations related to the May 2018 acquisition of Vievu LLC.
  • A patent infringement suit filed by Airspace Systems, Inc. against Dedrone (Eastern District of Virginia, Case No. 1:24-CV-01625) involving drone technology, with Axon added as a defendant after acquiring Dedrone. Litigation is stayed pending Patent Trial and Appeal Board review.

Stakeholder Impact

  • Shareholders: Face potential dilution from stock-based compensation and equity offerings, and a significant decrease in net income and EPS may negatively impact stock price. The material weakness in internal controls could erode investor confidence.
  • Employees: Benefit from increased headcount (24% growth in 2025) and competitive compensation/benefits, but also subject to non-recurring severance costs and potential impacts of management turnover.
  • Customers (especially law enforcement): Benefit from continued product innovation, integrated hardware/software solutions, and strategic acquisitions enhancing public safety capabilities. However, budgetary constraints and product defects/security breaches remain concerns.
  • Suppliers: Continued reliance on domestic and international suppliers, with risks related to supply chain disruptions, tariffs, and potential ethical sourcing issues.
  • Creditors: Impacted by the issuance of $1.75 billion in Senior Notes and the early repurchase of 2027 Notes, as well as restrictive covenants in debt agreements.

Next Steps

  • Continue remediation efforts to address the material weakness in internal control over financial reporting related to revenue recognition.
  • Complete the purchase price allocation for the Prepared acquisition by the third quarter of 2026.
  • Monitor legislative developments regarding the OECD global minimum tax framework and assess potential future impacts.
  • Potentially consider repurchases of common stock, subject to authorization and market conditions.
  • Opportunistically issue new debt securities to fund growth or refinance future debt maturities.
  • Continue to identify and implement changes to recruiting personnel, methodology, and approach to address a changing candidate pool and profile.

Key Dates

DateDescription
1993Company founded as ICER Corporation.
December 1993Name changed to AIR TASER, Inc.
April 1998Name changed to TASER International, Incorporated.
January 2001Reincorporated in Delaware as TASER International, Inc.
February 2016Board of Directors authorized a $50.0 million stock repurchase program.
April 2017Name changed to Axon Enterprise, Inc.
May 24, 2018Shareholders approved the 2018 CEO Performance Award for Patrick Smith.
September 2019Board of Directors adopted the Axon Enterprise, Inc. 2019 Stock Inducement Plan.
June 2022Entered into a six-year purchase agreement for cloud hosting with a total commitment of $425.0 million.
September 2022Board of Directors adopted the Axon Enterprise, Inc. 2022 Stock Inducement Plan.
December 2022Issued $690.0 million aggregate principal amount of Convertible Senior Notes due 2027 (2027 Notes) and entered into a convertible note hedge transaction and warrant transactions.
June 30, 2023The 2018 CEO Performance Award was fully vested.
October 2023Federal Trade Commission (FTC) dismissed its administrative enforcement complaint against Axon regarding the Vievu LLC acquisition.
January 31, 2024Acquired the remaining 79.7% equity interests in Fusus, LLC.
February 2024Current Chief Information Security Officer (CISO) began serving in the role.
May 10, 2024Shareholders approved the Employee eXponential Stock Plan (Employee XSP) and a grant of XSUs to CEO Patrick Smith (CEO Performance Award).
October 1, 2024Acquired the remaining 79.8% equity interests in Dedrone.
March 2025Issued $1.0 billion aggregate principal amount of Senior Notes due 2030 and $750.0 million aggregate principal amount of Senior Notes due 2033. Also amended the Credit Agreement, increasing the revolving credit facility to $300.0 million and extending its maturity to March 11, 2030.
June 2025Tranche 1 of the Employee XSP and CEO Performance Award vested and settled.
June 30, 2025Aggregate market value of common stock held by non-affiliates was approximately $62.2 billion.
July 4, 2025The One Big Beautiful Bill Act was signed into law, impacting deferred income taxes.
October 1, 2025Acquired the remaining 99.2% interest in Invictus Apps, Inc. (Prepared).
October 8, 2025The Patent Trial and Appeal Board granted Axon's petitions and instituted review on all claims of three asserted patents in the Airspace Systems, Inc. vs. Dedrone patent infringement suit.
November 14, 2025Julie Cullivan, Director, adopted a Rule 10b5-1 trading arrangement.
December 8, 2025Cameron Brooks, Chief Revenue Officer, and Jeri Williams, Director, adopted Rule 10b5-1 trading arrangements.
December 17, 2025Joshua Isner, President, and Hadi Partovi, Director, adopted Rule 10b5-1 trading arrangements.
December 18, 2025Delivered a notice of redemption for all outstanding 2027 Notes.
December 31, 2025Fiscal year end. Tranche 2 of the Employee XSP and CEO Performance Award vested and settled. Material weakness in internal control over financial reporting related to revenue recognition still existed.
February 10, 2026Redeemed $0.8 million aggregate principal amount of the 2027 Notes.
February 11, 2026Settled conversions in respect of $80.3 million aggregate principal amount of the 2027 Notes with cash and common stock, resulting in no 2027 Notes outstanding.
February 18, 2026Number of common stock shares outstanding was 80,397,675.
February 2026Acquired Carbyne Ltd. for a base purchase price of $625.0 million. Also closed a series of transactions to acquire additional equity interests in new and existing strategic investees for $234.3 million.
October 8, 2026Expected decision date for the Patent Trial and Appeal Board review on Airspace Systems, Inc. patents.
Third quarter of 2026Expected completion of the purchase price allocation for the Prepared acquisition.
March 15, 2027Earliest optional redemption date for 2030 Notes at 100% principal plus make whole premium.
December 15, 2027Maturity date for 2027 Notes (though fully redeemed/converted in Feb 2026). Expiration date for 2027 Note Hedge.
March 15, 2028First expiration date for 2027 Warrants. Earliest optional redemption date for 2033 Notes at 100% principal plus make whole premium.
December 15, 2028Minimum service requirement expiration for Tranche 1 and 2 of CEO Performance Award.
March 11, 2030Maturity date for the Credit Agreement.
March 15, 2030Maturity date for 2030 Notes.
December 31, 2030Holding period expiration for certain Tranche 2 XSU grantees (earlier of this date or subsequent tranche vesting).
March 15, 2033Maturity date for 2033 Notes.

Recommendation

hold

Axon demonstrates strong top-line growth and strategic expansion through acquisitions, particularly in high-growth areas like AI and drone technology. However, the significant decline in net income and EPS, coupled with a reported operating loss and an identified material weakness in internal controls, signals underlying profitability and operational efficiency challenges. While the long-term vision and market position are compelling, these financial and control issues warrant caution. A 'hold' recommendation is appropriate for investors to observe if management can effectively remediate the control weakness and translate robust revenue growth into sustainable profitability, especially given the substantial increase in operating expenses and stock-based compensation.

Keywords

Public Safety Technology, Body Cameras, TASER, SaaS, Digital Evidence Management, AI, Drones, Counter-Drone Technology, Law Enforcement Solutions, Cloud Software, Connected Devices, Government Contracts, Cybersecurity, Financial Reporting, SEC Filing, AXON

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.